S1823 Comparative Analysis of Clinical Outcomes in Hepatitis B/Delta Virus Co-infection vs Hepatitis B Mono-Infection in a Large Integrated Healthcare System
Li, Xiaoran, Tucker, Lue-Yen, Chai, Krisna P., Seo, Suk, Mukhtar, Nizar, Chee, Grace M., Kwon, Kyung, Balasubramanian, Sripriya, Macdonald, Brock, Schmittdiel, Julie, Saxena, Varun
Published in The American journal of gastroenterology (01.10.2024)
Published in The American journal of gastroenterology (01.10.2024)
Get full text
Journal Article
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial
Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Berger, Annemarie, Ciesek, Sandra, Manuilov, Dmitry, Mercier, Renee-Claude, Da, Ben L., Chee, Grace M., Li, Mingyang, Flaherty, John F., Lau, Audrey H., Osinusi, Anu, Schulze zur Wiesch, Julian, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro
Published in Journal of hepatology (01.10.2024)
Published in Journal of hepatology (01.10.2024)
Get full text
Journal Article
FRI-383 Unique characteristics and risk of liver-related events among individuals with hepatitis D virus infection with and without concurrent hepatitis C virus infection: a United States administrative claims analysis
Telep, Laura, Wyles, David, Chee, Grace M., Chokkalingam, Anand, Singer, Amanda, Kushner, Tatyana
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
FRI-407 Screening rates, prevalence, and natural history of hepatitis B/ delta virus co-infection vs. hepatitis B mono-infection: data from a large US integrated healthcare system
Saxena, Varun, Tucker, Lue-Yen, Li, Xiaoran, Chai, Krisna, Seo, Suk, Mukhtar, Nizar, Chee, Grace M., Kwon, Kyung Min, Balasubramanian, Sreepriya, Macdonald, Brock, Schmittdiel, Julie
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
SAT-373 Intrahepatic sodium taurocholate co-transporting polypeptide gene transcript and membrane-localized protein expression changes in chronic hepatitis D patients following 48 weeks of treatment with Bulevirtide
Nieves, Wildaliz, Pan, David, Aggarwal, Abhishek, Zaboli, Shiva, Moon, Christina, Diehl, Lauri, Ni, Liyun, Manhas, Savrina, Mo, Hongmei, Allweiss, Lena, Manuilov, Dmitry, Chee, Grace M., Mercier, Renee-Claude, Wallin, Jeffrey, Dandri-Petersen, Maura
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
WED-392 Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48weeks of bulevirtide monotherapy
Lampertico, Pietro, Aleman, Soo, Bogomolov, Pavel, Stepanova, Tatyana, Cornberg, Markus, Ciesek, Sandra, Berger, Annemarie, Manuilov, Dmitry, Li, Mingyang, Lau, Audrey H., Da, Ben L., Chee, Grace M., Brunetto, Maurizia, Zeuzem, Stefan, Wedemeyer, Heiner
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
FRI-371 Undetectable HDV RNA at 24 weeks of treatment with combination therapy is an important predictor of maintained response off-therapy
Zoulim, Fabien, Chulanov, Vladimir, Lampertico, Pietro, Wedemeyer, Heiner, Streinu-Cercel, Adrian, Pantea, Victor, Lazar, Stefan, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Syutkin, Vladimir, Sagalova, Olga, Manuilov, Dmitry, Mercier, Renee-Claude, Ye, Lei, Chee, Grace M., Da, Ben L., Lau, Audrey H., Osinusi, Anu, Bourliere, Marc, Ratziu, Vlad, Pol, Stanislas, Hilleret, Marie-Noëlle, Asselah, Tarik
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
WED-395 Undetectable hepatitis delta virus RNA at the end of treatment with bulevirtide and pegylated interferon alpha-2a is an important predictor of 48 weeks sustained virologic response in chronic hepatitis delta
Zoulim, Fabien, Asselah, Tarik, Chulanov, Vladimir, Streinu-Cercel, Adrian, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Sagalova, Olga, Mercier, Renee-Claude, Ye, Lei, Manuilov, Dmitry, Lau, Audrey H., Chee, Grace M., Da, Ben L., Bourliere, Marc, Wedemeyer, Heiner, Lampertico, Pietro
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
GS-002 48-week off-therapy efficacy and safety of bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta: final results from the phase 2b, open-label, randomised, multicentre study MYR204
Asselah, Tarik, Chulanov, Vladimir, Lampertico, Pietro, Wedemeyer, Heiner, Streinu-Cercel, Adrian, Pantea, Victor, Lazar, Stefan, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Syutkin, Vladimir, Sagalova, Olga, Manuilov, Dmitry, Mercier, Renee-Claude, Ye, Lei, Chee, Grace M., Da, Ben L., Lau, Audrey H., Osinusi, Anu, Bourliere, Marc, Ratziu, Vlad, Pol, Stanislas, Hilleret, Marie-Noëlle, Zoulim, Fabien
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
TOP-400 Impact of bulevirtide given with or without nucleos (t)ide analogues on 48-week virologic outcomes in patients with chronic hepatitis delta virus infection
Lampertico, Pietro, Brunetto, Maurizia, Buti, Maria, Aleman, Soo, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Flaherty, John F., Li, Mingyang, Manuilov, Dmitry, Da, Ben L., Mercier, Renee-Claude, Chee, Grace M., Cornberg, Markus, Wedemeyer, Heiner, Asselah, Tarik
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
LBP-029 Efficacy and safety of 144 weeks of bulevirtide 2 mg or 10 mg monotherapy from the ongoing phase 3 study, MYR301
Lampertico, Pietro, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Chee, Grace M., Manuilov, Dmitry, Li, Mingyang, Tseng, Steve, Lau, Audrey, Osinusi, Anu, zur Wiesch, Julian Schulze, Cornberg, Markus, Zeuzem, Stefan, Wedemeyer, Heiner
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial
Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Berger, Annemarie, Ciesek, Sandra, Manuilov, Dmitry, Mercier, Renee-Claude, Da, Ben L, Chee, Grace M, Li, Mingyang, Flaherty, John F, Lau, Audrey H, Osinusi, Anu, Schulze Zur Wiesch, Julian, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro
Published in Journal of hepatology (09.05.2024)
Get full text
Published in Journal of hepatology (09.05.2024)
Journal Article